Chile vs Tajikistan: Access to anti-retroviral drugs, male
Chile
73.0%
in 2024
Tajikistan
72.0%
in 2024
Chile rank
62nd
Tajikistan rank
65th
Access to anti-retroviral drugs, male over time
- Chile
- Tajikistan
How they compare
Chile currently reports 73.0% against 72.0% in Tajikistan, a difference of 1.0%.
Across all 25 years both countries report, Chile has been ahead every year.
Chile ranks 62nd and Tajikistan ranks 65th of 141 countries.
Chile has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chile | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 25.7% | 0.7% | 25.0% | Chile |
| 2010s | 57.0% | 19.3% | 37.7% | Chile |
| 2020s | 76.6% | 59.2% | 17.4% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Chile or Tajikistan?
- Chile, at 73.0% against 72.0% in Tajikistan as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Chile and Tajikistan?
- 1.0%, with Chile ahead.
- How many years of comparable data are there for Chile and Tajikistan?
- 25 years are reported by both, from 2000 to 2024.
- How do Chile and Tajikistan rank globally for access to anti-retroviral drugs, male?
- Chile ranks 62nd and Tajikistan ranks 65th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.